Manulife (Manufacturers Life Insurance)
CNCE

Manulife (Manufacturers Life Insurance)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,140
Closed -$76K – 3321
2021
Q1 		$76K Sell
15,140
-5,018
-25% -$40.6K ﹤0.01% 3061
2020
Q4 		$255K Buy
20,158
+2,126
+12% +$24.2K ﹤0.01% 2614
2020
Q3 		$177K Hold
18,032
– – ﹤0.01% 2618
2020
Q2 		$171K Buy
18,032
+1,688
+10% +$16.2K ﹤0.01% 2569
2020
Q1 		$144K Buy
16,344
+2,249
+16% +$22.2K ﹤0.01% 2459
2019
Q4 		$130K Sell
14,095
-1,317
-9% -$9.33K ﹤0.01% 2730
2019
Q3 		$96K Hold
15,412
– – ﹤0.01% 2830
2019
Q2 		$185K Buy
+15,412
New +$166K ﹤0.01% 2689
2018
Q3 		– Sell
-16,800
Closed -$283K – 4016
2018
Q2 		$283K Buy
16,800
+3,072
+22% +$59.7K ﹤0.01% 2836
2018
Q1 		$314K Sell
13,728
-441
-3% -$9.81K ﹤0.01% 2689
2017
Q4 		$366K Sell
14,169
-1,047
-7% -$21.1K ﹤0.01% 2542
2017
Q3 		$225K Buy
15,216
+164
+1% +$2.38K ﹤0.01% 2889
2017
Q2 		$210K Buy
15,052
+287
+2% +$4.23K ﹤0.01% 2971
2017
Q1 		$252K Buy
14,765
+594
+4% +$7.12K ﹤0.01% 2669
2016
Q4 		$145K Buy
14,171
+1,346
+10% +$12.3K ﹤0.01% 3026
2016
Q3 		$130K Hold
12,825
– – ﹤0.01% 3073
2016
Q2 		$144K Buy
12,825
+2,099
+20% +$26.7K ﹤0.01% 2984
2016
Q1 		$141K Buy
10,726
+242
+2% +$3.48K ﹤0.01% 2853
2015
Q4 		$199 Buy
10,484
+127
+1% +$2.76K ﹤0.01% 2671
2015
Q3 		$195 Hold
10,357
– – ﹤0.01% 2673
2015
Q2 		$154 Buy
10,357
+9,767
+1,655% +$149K ﹤0.01% 3085
2015
Q1 		$9 Hold
590
– – ﹤0.01% 3579
2014
Q4 		$8 Buy
+590
New +$7.62K ﹤0.01% 3498

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CNCE Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 15,140 shares — an estimated $76K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CNCE in Q4 2014 and held it in 23 quarters. The position peaked at $366K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 15,140 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $76K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Concert Pharmaceuticals, Inc. in Q4 2014 and held it in 23 quarters.
  • Manulife (Manufacturers Life Insurance)'s Concert Pharmaceuticals, Inc. position peaked at $366K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.